Header Logo

Connection

Yehuda Handelsman to Cohort Studies

Back to Details
This is a "connection" page, showing publications Yehuda Handelsman has written about Cohort Studies.
Yehuda Handelsman
Connection Strength
0.127
Cohort Studies
  1. Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II. Diabetes Obes Metab. 2017 07; 19(7):989-996.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.